NCT02598245

Brief Summary

Transobturator tapes (TOT) are placed according to the surgical technique described by Delorme et al. in patients with a previous cervico-sacropexy (CESA) or vagino-sacropexy (VASA). Before final Fixation of the tapes and suturing the vaginal skin a Hegar dilator sound with either 8 mm or 6 mm diameter is placed in the urethra and a second Hegar dilator sound with either 4 mm or 3 mm diameter is placed between the tape and the urethra. After suturing the vaginal skin the Hegar sounds are removed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 4, 2015

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 5, 2015

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

November 5, 2015

Status Verified

November 1, 2015

Enrollment Period

3.9 years

First QC Date

November 4, 2015

Last Update Submit

November 4, 2015

Conditions

Keywords

urinary incontinence, CESA, VASA, TOT, TVT

Outcome Measures

Primary Outcomes (1)

  • Distance between urethra and transobturator sling

    transvaginal ultrasound measurements

    2 weeks

Secondary Outcomes (1)

  • Distance between urethra and transobturator sling

    16 weeks

Study Arms (2)

TOT 8/4

ACTIVE COMPARATOR

Transobturator sling (TOT) is placed according to the original description. Instead of a "Metzenbaum Scissor" which should guarantee the distance between the urethra and the sling a Hegar dilator sound of 4 mm diameter is used (Hegar 4). An additional Hegar dilator sound of 8 mm is placed in the urethra before tightening the sling and suturing the vaginal skin.

Device: TOT 8/4

TOT 6/3

EXPERIMENTAL

Transobturator sling (TOT) is placed according to the original description. Instead of a "Metzenbaum Scissor" which should guarantee the distance between the urethra and the sling a Hegar dilator sound of 3 mm diameter is used (Hegar 3). An additional Hegar dilator Sound of 6 mm is placed in the urethra before tightening the sling and suturing the vaginal skin.

Device: TOT 6/3

Interventions

TOT 8/4DEVICE

placement of transobturator sling according to the TOT 8/4 technique

TOT 8/4
TOT 6/3DEVICE

placement of transobturator sling according to the TOT 6/3 technique

TOT 6/3

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • urinary incontinence

You may not qualify if:

  • previous TOT or TVT

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Obstetrics and Gynecology, University of Cologne

Cologne, North Rhine-Westphalia, 50931, Germany

RECRUITING

MeSH Terms

Conditions

Urinary Incontinence

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Wolfram Jager, Professor

    Head of the Department of Urogyne

    STUDY DIRECTOR

Central Study Contacts

Sebastian Ludwig, MD

CONTACT

Wolfram Jager, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 4, 2015

First Posted

November 5, 2015

Study Start

January 1, 2015

Primary Completion

December 1, 2018

Study Completion

April 1, 2019

Last Updated

November 5, 2015

Record last verified: 2015-11

Locations